A carregar...
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma
Introduction: The appraisal of medicines is often a complex and iterative process. We compared the health technology assessment (HTA) process in England and France taking as a case study the example of ixazomib for multiple myeloma. Methods: We undertook an analysis of eight relevant published docum...
Na minha lista:
| Publicado no: | J Mark Access Health Policy |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Routledge
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6711145/ https://ncbi.nlm.nih.gov/pubmed/31489149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2019.1648971 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|